small lymphocytic lymphoma (sll)
Showing 1 - 19 of 19
Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing
Recruiting
- Relapsed or Refractory B-cell Lymphoma
- +6 more
-
Beijing, ChinaBeijing Cancer Hospital
Feb 6, 2023
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting
Enrolling by invitation
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- 5:2 Method (intermittent fasting regimen)
- 16/8 Method (intermittent fast regimen)
-
Victoria, British Columbia, CanadaEleah Stringer
Feb 2, 2023
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Venetoclax
- +2 more
-
Nagoya-shi, Aichi, Japan
- +19 more
Jan 25, 2023
Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston
Recruiting
- Mantle Cell Lymphoma
- +9 more
- L-Bcl-2 antisense oligonucleotide
-
Augusta, Georgia
- +2 more
Nov 18, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +7 more
-
Manchester, United Kingdom
- +2 more
Aug 11, 2022
Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL) Trial in United States (voruciclib
Recruiting
- Follicular Lymphoma (FL)
- +6 more
- voruciclib monotherapy
- voruciclib and venetoclax
-
Duarte, California
- +10 more
Aug 10, 2022
Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States
Recruiting
- Relapsed/Refractory B-cell Lymphomas
- +11 more
- CLBR001 and SWI019
-
Duarte, California
- +7 more
Jul 26, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
-
Duarte, California
- +10 more
Jul 14, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Venetoclax monotherapy, Venetoclax
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Venetoclax monotherapy
- Venetoclax with anti CD20 monoclonal antibody
-
Basking Ridge, New Jersey
- +9 more
Mar 15, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)
Active, not recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
-
Rochester, New YorkUniversity of Rochester
Feb 7, 2022
Safety and Tolerability, Compare SHINGRIX Vaccine Response Rates, Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI
Active, not recruiting
- Safety and Tolerability
- +3 more
- Zoster Vaccine Recombinant, Adjuvanted
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,
Active, not recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Obinutuzumab
- +2 more
-
Tempe, Arizona
- +14 more
Jan 12, 2022
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
- ME-401
- +2 more
-
Tucson, Arizona
- +23 more
Dec 14, 2021
Non-Hodgkin Lymphoma (NHL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL) Trial in Japan (azacitadine, venetoclax,
Completed
- Non-Hodgkin Lymphoma (NHL)
- +4 more
- azacitadine
- +2 more
-
Nagoya shi, Aichi, Japan
- +13 more
Jul 29, 2021
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial (Bendamustine and Rituximab Induction followed by
Withdrawn
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Bendamustine and Rituximab Induction followed by Rituximab and Lenalidomide Maintenance
- (no location specified)
Nov 13, 2019
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), B-Cell Non-Hodgkin Lymphomas(NHL) Trial in Nanjing,
Unknown status
- Chronic Lymphocytic Leukemia (CLL)
- +2 more
-
Nanjing, Jiangsu, China
- +1 more
Apr 27, 2019
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Idelalisib, Rituximab)
Terminated
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
-
La Jolla, California
- +5 more
Oct 19, 2018
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in La Jolla, Columbus, Houston (plerixafor)
Completed
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
-
La Jolla, California
- +2 more
Mar 19, 2015